Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the field of biopharmaceuticals, featuring promising enhancements throughout various health care and industrial apps. With its structural similarity to By natural means derived human serum albumin, OsrHSA provides a safer, more dependable substitute for therapeutic